Annual report pursuant to section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v2.4.0.8
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
12 Months Ended 67 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
COSTS AND EXPENSES:      
Research and development $ 2,583,308 $ 1,158,167 $ 4,535,262
General and administrative 4,078,102 2,220,361 8,333,349
Total operating expenses 6,661,410 3,378,528 12,868,611
Operating Loss (6,661,410) (3,378,528) (12,868,611)
Gain on extinguishment of debt 0 0 7,908
Other income 1,875 0 1,875
Change in fair value of warrants liability (1,177,026) 0 (1,177,026)
Interest and other financing costs, net (1,613,039) (91,585) (1,808,426)
NET LOSS $ (9,449,600) $ (3,470,113) $ (15,844,280)
Net loss per common share, basic and diluted (in dollars per share) $ (5.58) $ (3.24)  
Weighted average common shares outstanding, basic and diluted (in shares) 1,693,436 1,071,295